课题基金 / 基金详情

Synthesis and Evaluation of Novel Antitumor Agents

Synthesis and Evaluation of Novel Antitumor Agents
新型抗肿瘤药物的合成与评价
批准号:
6689646
负责人:
YUQIANG WANG
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2004-07-31

项目摘要

项目成果

YUQIANG WANG的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Recently, tumor cells have been found to selectively accumulate certain n-3 fatty acids such as cis-4,7,10,13,16,19-docosahexenoic acid (DHA). DHA-paclitaxel, a conjugate of DHA and paclitaxel, has greatly increased therapeutic efficacy and reduced side effects in both the experimental animals and patients compared to free paclitaxel. We have synthesized over 100 novel CC-1065 analogues. These compounds are among the most potent anticancer agents found to date. We have uncovered important structural features that increase antitumor therapeutic efficacy and reduce toxicity. The objectives of this proposal are to synthesize and evaluate novel CC-1065 analogues that incorporate all of the newly discovered beneficial structural features. In addition, DHA will be conjugated to further increase the therapeutic efficacy and reduce toxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Tumor-selective Anticancer Agents
  • 批准号:
    6739779
  • 项目类别:
  • 资助金额:
    $14.6万
  • 财政年份:
    2004
  • 负责人:
    YUQIANG WANG
  • 依托单位:
Novel NMDA Receptor-Binding Drugs for Ischemia/Stroke
  • 批准号:
    6550204
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2002
  • 负责人:
    YUQIANG WANG
  • 依托单位:
SYNTHESIS AND EVALUTATION OF CATIONIC ANTITUMOR AGENTS
  • 批准号:
    6420493
  • 项目类别:
  • 资助金额:
    $25.0万
  • 财政年份:
    2001
  • 负责人:
    YUQIANG WANG
  • 依托单位:
SYNTHESIS AND EVALUTATION OF CATIONIC ANTITUMOR AGENTS
  • 批准号:
    6288049
  • 项目类别:
  • 资助金额:
    $24.44万
  • 财政年份:
    2001
  • 负责人:
    YUQIANG WANG
  • 依托单位: